CDMO News Days Hours Minutes Seconds Download Full Agenda CDMO News Samsung Biologics Signs $262M Manufacturing Deal With European Pharma Company Samsung Biologics Signs $262M Manufacturing Deal With European Pharma Company GBI Biomanufacturing Appoints Jesse McCool as CEO Shilpa Medicare Launches Dedicated Complex Small-Molecule CDMO CordenPharma Commits $93.1 Million to Expand Injectable Manufacturing in Italy Lonza Plans Commercial Spray-Drying Facility in Oregon Cellipont Bioservices and Xiogenix Assess Automated Cell Therapy Fill-Finish EpilepsyGTx Partners With Viralgen to Manufacture EPY201 Gene Therapy Ensera Forms Strategic Alliance With American Injectables eXoZymes Partners With Curia for NCT Technology Transfer and Scale-Up IOL Chemicals Invests $36.8 Million in Ibuprofen Capacity Expansion VVMF Receives TGA Manufacturing Licence for Sydney Viral Vector Facility More CDMO News GBI Biomanufacturing Appoints Jesse McCool as CEO Shilpa Medicare Launches Dedicated Complex Small-Molecule CDMO CordenPharma Commits $93.1 Million to Expand Injectable Manufacturing in Italy Lonza Plans Commercial Spray-Drying Facility in Oregon Cellipont Bioservices and Xiogenix Assess Automated Cell Therapy Fill-Finish EpilepsyGTx Partners With Viralgen to Manufacture EPY201 Gene Therapy Ensera Forms Strategic Alliance With American Injectables eXoZymes Partners With Curia for NCT Technology Transfer and Scale-Up IOL Chemicals Invests $36.8 Million in Ibuprofen Capacity Expansion VVMF Receives TGA Manufacturing Licence for Sydney Viral Vector Facility More CDMO News White Paper[Download] MASTERCLASS: Where Pre-Filled Syringe Tech Transfers Go Wrong RESOURCES AI Pilots and Strategic Partnerships: ExM Leaders Basel 2026 Report Resilience, Risk & Relationships – ExM Leaders Report [DOWNLOAD] Partnerships for an Uncertain World: The CDMO Live Europe 2026 Report
